281 related articles for article (PubMed ID: 28973433)
1. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
[TBL] [Abstract][Full Text] [Related]
2. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
3. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
5. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
6. Elucidation of the role of LMO2 in human erythroid cells.
Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
[TBL] [Abstract][Full Text] [Related]
7. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
9. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins.
Wadman IA; Osada H; Grütz GG; Agulnick AD; Westphal H; Forster A; Rabbitts TH
EMBO J; 1997 Jun; 16(11):3145-57. PubMed ID: 9214632
[TBL] [Abstract][Full Text] [Related]
10. VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus.
Ciau-Uitz A; Pinheiro P; Kirmizitas A; Zuo J; Patient R
Development; 2013 Jun; 140(12):2632-42. PubMed ID: 23637333
[TBL] [Abstract][Full Text] [Related]
11. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis shows that Ldb1 controls essential hematopoietic genes/pathways in mouse early development and reveals novel players in hematopoiesis.
Mylona A; Andrieu-Soler C; Thongjuea S; Martella A; Soler E; Jorna R; Hou J; Kockx C; van Ijcken W; Lenhard B; Grosveld F
Blood; 2013 Apr; 121(15):2902-13. PubMed ID: 23390196
[TBL] [Abstract][Full Text] [Related]
13. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
14. HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias.
Calero-Nieto FJ; Joshi A; Bonadies N; Kinston S; Chan WI; Gudgin E; Pridans C; Landry JR; Kikuchi J; Huntly BJ; Gottgens B
Oncogene; 2013 Nov; 32(48):5471-80. PubMed ID: 23708655
[TBL] [Abstract][Full Text] [Related]
15. Building multifunctionality into a complex containing master regulators of hematopoiesis.
Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
[TBL] [Abstract][Full Text] [Related]
16. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
[TBL] [Abstract][Full Text] [Related]
17. The LMO2 -25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity.
Bonadies N; Göttgens B; Calero-Nieto FJ
PLoS One; 2015; 10(7):e0131577. PubMed ID: 26161748
[TBL] [Abstract][Full Text] [Related]
18. Runx genes are direct targets of Scl/Tal1 in the yolk sac and fetal liver.
Landry JR; Kinston S; Knezevic K; de Bruijn MF; Wilson N; Nottingham WT; Peitz M; Edenhofer F; Pimanda JE; Ottersbach K; Göttgens B
Blood; 2008 Mar; 111(6):3005-14. PubMed ID: 18184866
[TBL] [Abstract][Full Text] [Related]
19. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
[TBL] [Abstract][Full Text] [Related]
20. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
Patterson LJ; Gering M; Eckfeldt CE; Green AR; Verfaillie CM; Ekker SC; Patient R
Blood; 2007 Mar; 109(6):2389-98. PubMed ID: 17090656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
